Journal Image
Current Cancer Drug Targets
ISSN (Print): 1568-0096
ISSN (Online): 1873-5576
Quick Track
DOI: 10.2174/15680096113138880006      Price:  $95

Current and Potential Treatments for Cervical Cancer

Author(s): Grace P.C. Yee, Paul de Souza and Levon M. Khachigian
Pages 1-16 (16)
Cervical cancer is the third most common carcinoma in women worldwide. Despite increasing efforts to improve therapy in this disease, a significant proportion of women still die, mostly from recurrent or chemoresistant disease. This review discusses current treatments for early cervical cancer, advanced disease, and recurrent cervical cancer, and covers concurrent chemoradiation, neoadjuvant chemotherapy before surgery and radiation, single agent treatment, combination treatment, platinum-based and non-platinum based therapy. We also discuss promising therapeutic strategies for cervical cancer including targeted therapy, cell-based therapy, combined siRNA and chemotherapy, and immunotherapy.
Cervical cancer, side-effects, targeted, therapy
Centre for Vascular Research, University of New South Wales, Sydney, NSW 2052, Australia